Unknown

Dataset Information

0

Depletion of high-content CD14+ cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing.


ABSTRACT: With the US Food and Drug Administration (FDA) approval of four CD19- and one BCMA-targeted chimeric antigen receptor (CAR) therapy for B cell malignancies, CAR T cell therapy has finally reached the status of a medicinal product. The successful manufacturing of autologous CAR T cell products is a key requirement for this promising treatment modality. By analyzing the composition of 214 apheresis products from 210 subjects across eight disease indications, we found that high CD14+ cell content poses a challenge for manufacturing CAR T cells, especially in patients with non-Hodgkin's lymphoma and multiple myeloma caused by the non-specific phagocytosis of the magnetic beads used to activate CD3+ T cells. We demonstrated that monocyte depletion via rapid plastic surface adhesion significantly reduces the CD14+ monocyte content in the apheresis products and simultaneously boosts the CD3+ content. We established a 40% CD14+ threshold for the stratification of apheresis products across nine clinical trials and demonstrated the effectiveness of this procedure by comparing manufacturing runs in two phase 1 clinical trials. Our study suggests that CD14+ content should be monitored in apheresis products, and that the manufacturing of CAR T cells should incorporate a step that lessens the CD14+ cell content in apheresis products containing more than 40% to maximize the production success.

SUBMITTER: Wang X 

PROVIDER: S-EPMC8411225 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7056516 | biostudies-literature
| S-EPMC8662627 | biostudies-literature
| S-EPMC7011017 | biostudies-literature
| S-EPMC8860360 | biostudies-literature
| S-EPMC8462122 | biostudies-literature
| S-EPMC5796845 | biostudies-literature
| 2384781 | ecrin-mdr-crc
| S-EPMC11359676 | biostudies-literature
| S-EPMC8812682 | biostudies-literature
| S-EPMC9867937 | biostudies-literature